Spago Nanomedical AB

Spago Nanomedical is a biotechnology company with expert capabilities in contrast agent- and nanoscale life science research.

The main focus of the company is the development of an innovative and proprietary MRI (Magnetic Resonance Imaging) contrast agent, and the novel therapeutic project Tumorad for cancer selective radionuclide treatment. Spago Nanomedical encompasses many years of experience from contrast- and pharma industry, including discovery research, early clinical- and business development.

Kategorier: Medtech

Gå till Spago Nanomedical ABs hemsida